Related Experiment Video

Updated: Apr 18, 2026

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
04:12

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid

Published on: January 19, 2024

1.8K

Possible atomoxetine-induced vitiligo: a case report

Özlem Bilgiç1, Ayhan Bilgiç

  • 1Department of Dermatology, Faculty of Medicine, Selcuk University, Konya, Turkey.

Attention Deficit and Hyperactivity Disorders
|January 22, 2015
PubMed

Insights

Vitiligo, a skin condition causing white patches, may be linked to ADHD medications. A child developed vitiligo after starting atomoxetine, suggesting a potential connection between these drugs and the condition.

Area of Science:

  • Dermatology
  • Neuroscience
  • Pharmacology

Background:

  • Vitiligo is a chronic skin disease resulting in depigmented lesions due to melanocyte loss.
  • The exact cause of vitiligo remains unclear, but the neural theory suggests monoamine neurotransmitters contribute to melanocyte destruction.
  • Certain medications are implicated in vitiligo development, potentially via their effects on the monoaminergic system.

Observation:

  • A previous report noted localized pigmentation loss after methylphenidate patch use in an attention-deficit/hyperactivity disorder (ADHD) patient.
  • This case study details a school-aged child diagnosed with ADHD who developed a vitiligo lesion after initiating atomoxetine treatment.
  • Atomoxetine is a norepinephrine reuptake inhibitor used for ADHD management.

Findings:

  • The presented case suggests a possible association between atomoxetine, an ADHD medication, and the onset of vitiligo.
  • This observation aligns with the neural theory of vitiligo and the known effects of certain drugs on the monoaminergic system.

Implications:

  • Further research is warranted to explore the potential impact of ADHD medications on vitiligo development.
  • Understanding this link may inform clinical practice regarding medication choices and patient monitoring for individuals with ADHD.
  • This case contributes to the ongoing discussion about drug-induced vitiligo and its underlying mechanisms.

More Related Videos

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.7K
Studying Chronic Exposure of Mice to Ultraviolet B Radiation03:20

Studying Chronic Exposure of Mice to Ultraviolet B Radiation

Published on: August 19, 2025

2.2K

Related Concept Videos

Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
4.2K
Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
75
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
214
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
198
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
181